Meyka AI API is live for developers.Start building.
Advertisement
Veru Inc.

Veru Inc. Fundamental Analysis

VERUNASDAQ
HealthcareBiotechnology
$3.40
$0.83(19.62%)
U.S. Market opens in 45h 11m
Advertisement

Veru Inc. Fundamental Analysis

Veru Inc. (VERU) shows weak financial fundamentals with a PE ratio of -5.14, profit margin of 0.00%, and ROE of -53.43%. The company generates N/A in annual revenue with weak year-over-year growth of -1.00%.

Key Strengths

Cash Position41.78%
PEG Ratio-0.05
Current Ratio6.19

Areas of Concern

ROE-53.43%
Operating Margin0.00%
We analyze VERU's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -126.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-126.0/100

We analyze VERU's fundamental strength across five key dimensions:

Efficiency Score

Weak

VERU struggles to generate sufficient returns from assets.

ROA > 10%
-32.73%

Valuation Score

Excellent

VERU trades at attractive valuation levels.

PE < 25
-5.14
PEG Ratio < 2
-0.05

Growth Score

Moderate

VERU shows steady but slowing expansion.

Revenue Growth > 5%
-1.00%
EPS Growth > 10%
61.79%

Financial Health Score

Excellent

VERU maintains a strong and stable balance sheet.

Debt/Equity < 1
0.08
Current Ratio > 1
6.19

Profitability Score

Weak

VERU struggles to sustain strong margins.

ROE > 15%
-5342.56%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is VERU Expensive or Cheap?

P/E Ratio

VERU trades at -5.14 times earnings. This suggests potential undervaluation.

-5.14

PEG Ratio

When adjusting for growth, VERU's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Veru Inc. at 2.09 times its book value. This may indicate undervaluation.

2.09

EV/EBITDA

Enterprise value stands at -2.80 times EBITDA. This is generally considered low.

-2.80

How Well Does VERU Make Money?

Net Profit Margin

For every $100 in sales, Veru Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-53.43 in profit for every $100 of shareholder equity.

-53.43%

ROA

Veru Inc. generates $-32.73 in profit for every $100 in assets, demonstrating efficient asset deployment.

-32.73%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-1.20 in free cash annually.

$-1.20

FCF Yield

VERU converts -47.33% of its market value into free cash.

-47.33%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.14

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.19

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.53

vs 25 benchmark

ROA

Return on assets percentage

-0.33

vs 25 benchmark

ROCE

Return on capital employed

-0.75

vs 25 benchmark

How VERU Stacks Against Its Sector Peers

MetricVERU ValueSector AveragePerformance
P/E Ratio-5.1429.20 Better (Cheaper)
ROE-53.43%729.00% Weak
Net Margin0.00%-52856.00% (disorted) Weak
Debt/Equity0.080.49 Strong (Low Leverage)
Current Ratio6.194.43 Strong Liquidity
ROA-32.73%-20711.00% (disorted) Weak

VERU outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Veru Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-100.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

45.41%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-609.43%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ